Thematic Pro

clinicaltrialvanguard.com

uniQure Plans BLA Submission for AMT-130 Gene Therapy in Huntington’s Disease

Read the original →

What this article backs

• Amt 130 Gene Therapy ✚ Fda Approval
• Amt 130 Gene Therapy ↓ Mutant Huntingtin Protein

• Amt 130 Gene Therapy enables Fda Approval.
• Amt 130 Gene Therapy decreases Mutant Huntingtin Protein.

In its own words

uniQure Plans BLA Submission for AMT-130 Gene Therapy in Huntington's Disease

Corroborated by

• Illustration E

  The Other Shoe Drops: uniQure Shares Plans To Submit Licensing Application With The FDA for AMT-130 – HDBuzz

  en.hdbuzz.net · Jun 17, 2026 Standard

  Backs 1 claim

  • Amt 130 Gene Therapy ✚ Fda Approval

  Read article →